

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of telomerase activity (GO:0051972) | 9.38411046 |
| 2 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 9.25635030 |
| 3 | telomere maintenance via telomerase (GO:0007004) | 8.33110772 |
| 4 | negative regulation of DNA biosynthetic process (GO:2000279) | 7.86118438 |
| 5 | DNA damage response, detection of DNA damage (GO:0042769) | 7.77329393 |
| 6 | regulation of telomere maintenance (GO:0032204) | 7.72365477 |
| 7 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 7.70292224 |
| 8 | heart trabecula morphogenesis (GO:0061384) | 7.59486192 |
| 9 | artery development (GO:0060840) | 6.87789463 |
| 10 | lymphangiogenesis (GO:0001946) | 6.84390938 |
| 11 | positive regulation of response to oxidative stress (GO:1902884) | 6.37559724 |
| 12 | positive regulation of cellular response to oxidative stress (GO:1900409) | 6.37559724 |
| 13 | positive regulation of DNA biosynthetic process (GO:2000573) | 6.33941979 |
| 14 | RNA-dependent DNA replication (GO:0006278) | 6.24513925 |
| 15 | embryonic foregut morphogenesis (GO:0048617) | 6.07722344 |
| 16 | trabecula morphogenesis (GO:0061383) | 5.93221114 |
| 17 | endothelial cell differentiation (GO:0045446) | 5.44542005 |
| 18 | cell migration in hindbrain (GO:0021535) | 5.34702002 |
| 19 | interkinetic nuclear migration (GO:0022027) | 5.34383886 |
| 20 | response to ischemia (GO:0002931) | 5.32215831 |
| 21 | renal system development (GO:0072001) | 5.29292188 |
| 22 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.27181334 |
| 23 | cell adhesion mediated by integrin (GO:0033627) | 5.14643121 |
| 24 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.93933083 |
| 25 | cardiac right ventricle morphogenesis (GO:0003215) | 4.92340455 |
| 26 | brain morphogenesis (GO:0048854) | 4.92057421 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 4.88208400 |
| 28 | cerebral cortex neuron differentiation (GO:0021895) | 4.88084623 |
| 29 | hemidesmosome assembly (GO:0031581) | 4.69559250 |
| 30 | organ growth (GO:0035265) | 4.68617437 |
| 31 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 4.56775855 |
| 32 | activin receptor signaling pathway (GO:0032924) | 4.54698026 |
| 33 | response to acidic pH (GO:0010447) | 4.38177869 |
| 34 | superoxide anion generation (GO:0042554) | 4.25837126 |
| 35 | cellular response to pH (GO:0071467) | 4.25545299 |
| 36 | protein localization to vacuole (GO:0072665) | 3.84541231 |
| 37 | protein localization to lysosome (GO:0061462) | 3.84541231 |
| 38 | heart field specification (GO:0003128) | 3.82208614 |
| 39 | secondary heart field specification (GO:0003139) | 3.82208614 |
| 40 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.80648499 |
| 41 | type B pancreatic cell development (GO:0003323) | 3.68954382 |
| 42 | gastrulation with mouth forming second (GO:0001702) | 3.62554985 |
| 43 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.62507116 |
| 44 | NADH dehydrogenase complex assembly (GO:0010257) | 3.62507116 |
| 45 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.62507116 |
| 46 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.61476409 |
| 47 | protein polyglutamylation (GO:0018095) | 3.57292384 |
| 48 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.53453985 |
| 49 | pancreas development (GO:0031016) | 3.48738423 |
| 50 | single strand break repair (GO:0000012) | 3.36855370 |
| 51 | intra-S DNA damage checkpoint (GO:0031573) | 3.34512647 |
| 52 | positive regulation of TOR signaling (GO:0032008) | 3.30323987 |
| 53 | response to increased oxygen levels (GO:0036296) | 3.23411663 |
| 54 | response to hyperoxia (GO:0055093) | 3.23411663 |
| 55 | negative regulation of protein localization to cell surface (GO:2000009) | 3.22483268 |
| 56 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.20895565 |
| 57 | cell proliferation in forebrain (GO:0021846) | 3.10630809 |
| 58 | C4-dicarboxylate transport (GO:0015740) | 3.01594289 |
| 59 | retina development in camera-type eye (GO:0060041) | 2.98683164 |
| 60 | viral genome replication (GO:0019079) | 2.97105167 |
| 61 | insulin secretion (GO:0030073) | 2.93826265 |
| 62 | filopodium assembly (GO:0046847) | 2.91641575 |
| 63 | histone-serine phosphorylation (GO:0035404) | 2.88604595 |
| 64 | regulation of DNA biosynthetic process (GO:2000278) | 2.87875884 |
| 65 | respiratory burst (GO:0045730) | 2.87501660 |
| 66 | glycerophospholipid catabolic process (GO:0046475) | 2.84680369 |
| 67 | regulation of protein heterodimerization activity (GO:0043497) | 2.84506138 |
| 68 | cytoplasmic sequestering of transcription factor (GO:0042994) | 2.84285092 |
| 69 | cardiac muscle contraction (GO:0060048) | 2.82508611 |
| 70 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.81236204 |
| 71 | nodal signaling pathway (GO:0038092) | 2.81151510 |
| 72 | nucleus localization (GO:0051647) | 2.80652169 |
| 73 | exogenous drug catabolic process (GO:0042738) | 2.80364319 |
| 74 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.76868646 |
| 75 | DNA replication checkpoint (GO:0000076) | 2.76404577 |
| 76 | ventricular cardiac muscle cell development (GO:0055015) | 2.73133467 |
| 77 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.60657333 |
| 78 | nucleotide transmembrane transport (GO:1901679) | 2.60542742 |
| 79 | positive regulation of small GTPase mediated signal transduction (GO:0051057) | 2.60086261 |
| 80 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.59673731 |
| 81 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.58246321 |
| 82 | response to pH (GO:0009268) | 2.56106484 |
| 83 | telomere maintenance via telomere lengthening (GO:0010833) | 2.56058408 |
| 84 | diol metabolic process (GO:0034311) | 2.55143029 |
| 85 | neuron cell-cell adhesion (GO:0007158) | 2.54861469 |
| 86 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.52813851 |
| 87 | type B pancreatic cell proliferation (GO:0044342) | 2.50305588 |
| 88 | membrane tubulation (GO:0097320) | 2.48952515 |
| 89 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.48658798 |
| 90 | carnitine shuttle (GO:0006853) | 2.47444918 |
| 91 | specification of organ identity (GO:0010092) | 2.46965799 |
| 92 | protein complex biogenesis (GO:0070271) | 2.46953883 |
| 93 | negative regulation of muscle cell apoptotic process (GO:0010656) | 2.46750655 |
| 94 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.44221454 |
| 95 | neuron fate commitment (GO:0048663) | 2.43057360 |
| 96 | regulation of telomere maintenance via telomerase (GO:0032210) | 14.8803755 |
| 97 | negative regulation of telomerase activity (GO:0051974) | 14.2603296 |
| 98 | DNA damage induced protein phosphorylation (GO:0006975) | 13.4642881 |
| 99 | negative regulation of telomere maintenance (GO:0032205) | 12.8046024 |
| 100 | regulation of helicase activity (GO:0051095) | 11.8370762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 8.77988140 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 8.77516263 |
| 3 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 6.57629234 |
| 4 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 5.20416553 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.88008311 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.27452225 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25883436 |
| 8 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.40349306 |
| 9 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.28675305 |
| 10 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.27369264 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.16262369 |
| 12 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.13969751 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07307123 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.02215985 |
| 15 | TP53_16413492_ChIP-PET_HCT116_Human | 1.89119726 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75927017 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71590960 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71391039 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70397274 |
| 20 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.70078307 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68230107 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67076090 |
| 23 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.66519531 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64825542 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64468096 |
| 26 | STAT3_23295773_ChIP-Seq_U87_Human | 1.59776497 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55768831 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.51153269 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46094366 |
| 30 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.45482405 |
| 31 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44734568 |
| 32 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42273772 |
| 33 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41802829 |
| 34 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39001532 |
| 35 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36018523 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36018523 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.34496274 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33535937 |
| 39 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32504600 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32344823 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.28448310 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26682653 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26127597 |
| 44 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.20818298 |
| 45 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20235866 |
| 46 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14245403 |
| 47 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12302746 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.10919029 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08775095 |
| 50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08447829 |
| 51 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.03154112 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.02376307 |
| 53 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02067331 |
| 54 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.00280811 |
| 55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00150744 |
| 56 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.99751367 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97221550 |
| 58 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96110738 |
| 59 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96077209 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93401352 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92589720 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92500664 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.91974182 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91390463 |
| 65 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91238912 |
| 66 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91200964 |
| 67 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90958006 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90042464 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89825263 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89566670 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88706138 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88000288 |
| 73 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87397597 |
| 74 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86804667 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86641045 |
| 76 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.86000762 |
| 77 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.85744234 |
| 78 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84511917 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.84132028 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 0.83610692 |
| 81 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.80449780 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.80173929 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79845857 |
| 84 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.79806735 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.79067796 |
| 86 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77449486 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76953346 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76609779 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76500693 |
| 90 | TBL1_22424771_ChIP-Seq_293T_Human | 0.76206892 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.73639321 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73639321 |
| 93 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.73628769 |
| 94 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72779405 |
| 95 | JUN_21703547_ChIP-Seq_K562_Human | 0.71510664 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.70672196 |
| 97 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.70124994 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.69470068 |
| 99 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.69376240 |
| 100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.68536712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004270_analgesia | 6.39031962 |
| 2 | MP0004133_heterotaxia | 5.48513958 |
| 3 | MP0002163_abnormal_gland_morphology | 4.65067170 |
| 4 | MP0003880_abnormal_central_pattern | 4.54034928 |
| 5 | MP0005646_abnormal_pituitary_gland | 3.59037880 |
| 6 | MP0002102_abnormal_ear_morphology | 3.11357143 |
| 7 | MP0002127_abnormal_cardiovascular_syste | 3.08803049 |
| 8 | MP0006276_abnormal_autonomic_nervous | 2.97619840 |
| 9 | MP0005379_endocrine/exocrine_gland_phen | 2.96677184 |
| 10 | MP0004147_increased_porphyrin_level | 2.92779349 |
| 11 | MP0008775_abnormal_heart_ventricle | 2.78576403 |
| 12 | MP0005595_abnormal_vascular_smooth | 2.77894622 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.46877547 |
| 14 | MP0004272_abnormal_basement_membrane | 2.42110738 |
| 15 | MP0003646_muscle_fatigue | 2.14599003 |
| 16 | MP0000631_abnormal_neuroendocrine_gland | 2.00108245 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 1.98767206 |
| 18 | MP0009745_abnormal_behavioral_response | 1.98539155 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.96482360 |
| 20 | MP0009384_cardiac_valve_regurgitation | 1.88928850 |
| 21 | MP0000778_abnormal_nervous_system | 1.84769608 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.80897401 |
| 23 | MP0000647_abnormal_sebaceous_gland | 1.73661794 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.65185325 |
| 25 | MP0001485_abnormal_pinna_reflex | 1.63316557 |
| 26 | MP0004883_abnormal_blood_vessel | 1.57295620 |
| 27 | MP0003195_calcinosis | 1.57186479 |
| 28 | MP0002064_seizures | 1.56675921 |
| 29 | MP0001529_abnormal_vocalization | 1.54982153 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.48936158 |
| 31 | MP0009697_abnormal_copulation | 1.41607959 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.40224434 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.33962055 |
| 34 | MP0008995_early_reproductive_senescence | 1.32257890 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.20337664 |
| 36 | MP0000749_muscle_degeneration | 1.18044664 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.17485468 |
| 38 | MP0003122_maternal_imprinting | 1.15693228 |
| 39 | MP0003787_abnormal_imprinting | 1.12823133 |
| 40 | MP0005620_abnormal_muscle_contractility | 1.12089365 |
| 41 | MP0004811_abnormal_neuron_physiology | 1.10996406 |
| 42 | MP0000230_abnormal_systemic_arterial | 1.09697362 |
| 43 | MP0002168_other_aberrant_phenotype | 1.09468540 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.08728325 |
| 45 | MP0002557_abnormal_social/conspecific_i | 1.06909184 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.05049980 |
| 47 | MP0005330_cardiomyopathy | 1.03860860 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.02538836 |
| 49 | MP0002089_abnormal_postnatal_growth/wei | 1.01017382 |
| 50 | MP0002233_abnormal_nose_morphology | 1.00243933 |
| 51 | MP0002972_abnormal_cardiac_muscle | 0.99522828 |
| 52 | MP0005195_abnormal_posterior_eye | 0.99479785 |
| 53 | MP0005386_behavior/neurological_phenoty | 0.98490693 |
| 54 | MP0004924_abnormal_behavior | 0.98490693 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 0.97252580 |
| 56 | MP0000427_abnormal_hair_cycle | 0.96182093 |
| 57 | MP0003283_abnormal_digestive_organ | 0.96092296 |
| 58 | MP0004484_altered_response_of | 0.94472289 |
| 59 | MP0001968_abnormal_touch/_nociception | 0.92503351 |
| 60 | MP0000249_abnormal_blood_vessel | 0.90908488 |
| 61 | MP0008874_decreased_physiological_sensi | 0.90899910 |
| 62 | MP0001963_abnormal_hearing_physiology | 0.90016079 |
| 63 | MP0000920_abnormal_myelination | 0.89089916 |
| 64 | MP0001919_abnormal_reproductive_system | 0.87937458 |
| 65 | MP0002736_abnormal_nociception_after | 0.87365589 |
| 66 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85762708 |
| 67 | MP0005647_abnormal_sex_gland | 0.85413213 |
| 68 | MP0000343_altered_response_to | 0.85302361 |
| 69 | MP0005448_abnormal_energy_balance | 0.85180084 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 0.83204297 |
| 71 | MP0003693_abnormal_embryo_hatching | 0.80300116 |
| 72 | MP0004742_abnormal_vestibular_system | 0.79825552 |
| 73 | MP0002111_abnormal_tail_morphology | 0.78967826 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.77673105 |
| 75 | MP0009672_abnormal_birth_weight | 0.77387145 |
| 76 | MP0010329_abnormal_lipoprotein_level | 0.77212666 |
| 77 | MP0005385_cardiovascular_system_phenoty | 0.76403083 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 0.76403083 |
| 79 | MP0003448_altered_tumor_morphology | 0.73774358 |
| 80 | MP0005197_abnormal_uvea_morphology | 0.73188186 |
| 81 | MP0002272_abnormal_nervous_system | 0.71587374 |
| 82 | MP0009046_muscle_twitch | 0.71568353 |
| 83 | MP0003938_abnormal_ear_development | 0.70351630 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.70318557 |
| 85 | MP0000566_synostosis | 0.65253139 |
| 86 | MP0002184_abnormal_innervation | 0.64801878 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.64574925 |
| 88 | MP0008057_abnormal_DNA_replication | 0.63299016 |
| 89 | MP0003755_abnormal_palate_morphology | 0.61405361 |
| 90 | MP0005253_abnormal_eye_physiology | 0.60642458 |
| 91 | MP0003075_altered_response_to | 0.60487234 |
| 92 | MP0001970_abnormal_pain_threshold | 0.60282583 |
| 93 | MP0002751_abnormal_autonomic_nervous | 0.59802925 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.59774923 |
| 95 | MP0003861_abnormal_nervous_system | 0.59529669 |
| 96 | MP0003948_abnormal_gas_homeostasis | 0.58703725 |
| 97 | MP0000049_abnormal_middle_ear | 0.58122109 |
| 98 | MP0003121_genomic_imprinting | 0.58083842 |
| 99 | MP0005389_reproductive_system_phenotype | 0.57946397 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.56554839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Esophageal atresia (HP:0002032) | 9.62586530 |
| 2 | Abnormality of the aortic arch (HP:0012303) | 8.93226234 |
| 3 | Aplasia cutis congenita (HP:0001057) | 7.93998894 |
| 4 | Increased serum pyruvate (HP:0003542) | 6.91004284 |
| 5 | Gastrointestinal atresia (HP:0002589) | 6.03749541 |
| 6 | Abnormality of glycolysis (HP:0004366) | 5.86001020 |
| 7 | Milia (HP:0001056) | 5.02466607 |
| 8 | Increased connective tissue (HP:0009025) | 5.02228642 |
| 9 | Ureteral stenosis (HP:0000071) | 4.97316904 |
| 10 | Ureteral obstruction (HP:0006000) | 4.64178897 |
| 11 | Atrophic scars (HP:0001075) | 4.60413817 |
| 12 | Chronic hepatic failure (HP:0100626) | 4.46666145 |
| 13 | Hypokinesia (HP:0002375) | 4.42198458 |
| 14 | Fragile skin (HP:0001030) | 4.38599699 |
| 15 | Pterygium (HP:0001059) | 4.21406550 |
| 16 | Hyperventilation (HP:0002883) | 3.99606681 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.67659697 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.67659697 |
| 19 | Ectropion (HP:0000656) | 3.53735749 |
| 20 | Atrioventricular canal defect (HP:0006695) | 3.48702958 |
| 21 | Curly hair (HP:0002212) | 3.48218914 |
| 22 | Atonic seizures (HP:0010819) | 3.36303197 |
| 23 | Melanoma (HP:0002861) | 3.36262905 |
| 24 | Freckling (HP:0001480) | 3.31770079 |
| 25 | Recurrent corneal erosions (HP:0000495) | 3.30603354 |
| 26 | Ragged-red muscle fibers (HP:0003200) | 3.29207056 |
| 27 | High anterior hairline (HP:0009890) | 3.25156738 |
| 28 | Amblyopia (HP:0000646) | 3.19800860 |
| 29 | Tetraplegia (HP:0002445) | 3.19109528 |
| 30 | Small intestinal stenosis (HP:0012848) | 2.87662193 |
| 31 | Duodenal stenosis (HP:0100867) | 2.87662193 |
| 32 | Tubulointerstitial nephritis (HP:0001970) | 2.82248580 |
| 33 | Nephronophthisis (HP:0000090) | 2.74771365 |
| 34 | Blue irides (HP:0000635) | 2.65693690 |
| 35 | Neoplasm of the pancreas (HP:0002894) | 2.65285995 |
| 36 | Retinopathy (HP:0000488) | 2.60932817 |
| 37 | Diminished movement (HP:0002374) | 2.59318234 |
| 38 | Abnormality of the labia minora (HP:0012880) | 2.47842730 |
| 39 | True hermaphroditism (HP:0010459) | 2.44119964 |
| 40 | Abnormality of the prostate (HP:0008775) | 2.43408312 |
| 41 | Rimmed vacuoles (HP:0003805) | 2.34659818 |
| 42 | Abnormality of the duodenum (HP:0002246) | 2.33717989 |
| 43 | Status epilepticus (HP:0002133) | 2.33461456 |
| 44 | Hypoplasia of dental enamel (HP:0006297) | 2.32799578 |
| 45 | Hepatocellular necrosis (HP:0001404) | 2.30094913 |
| 46 | Inability to walk (HP:0002540) | 2.28379270 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.27275292 |
| 48 | Patellar aplasia (HP:0006443) | 2.22197885 |
| 49 | Cystic hygroma (HP:0000476) | 2.14845991 |
| 50 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.09621473 |
| 51 | CNS demyelination (HP:0007305) | 2.09056993 |
| 52 | Absent speech (HP:0001344) | 2.07331376 |
| 53 | Increased CSF lactate (HP:0002490) | 2.06598039 |
| 54 | Pancreatic cysts (HP:0001737) | 2.06242751 |
| 55 | Colon cancer (HP:0003003) | 2.00768518 |
| 56 | Focal seizures (HP:0007359) | 2.00423765 |
| 57 | Hypsarrhythmia (HP:0002521) | 1.99754611 |
| 58 | Broad-based gait (HP:0002136) | 1.98641113 |
| 59 | Redundant skin (HP:0001582) | 1.93731048 |
| 60 | Hepatic necrosis (HP:0002605) | 1.90262753 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 1.90128151 |
| 62 | Fair hair (HP:0002286) | 1.89452001 |
| 63 | Broad metatarsal (HP:0001783) | 1.88338630 |
| 64 | Impaired pain sensation (HP:0007328) | 1.88310715 |
| 65 | Abnormality of pain sensation (HP:0010832) | 1.88310715 |
| 66 | Attenuation of retinal blood vessels (HP:0007843) | 1.88094944 |
| 67 | Dialeptic seizures (HP:0011146) | 1.88069848 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 1.83962312 |
| 69 | Pancreatic fibrosis (HP:0100732) | 1.83933754 |
| 70 | Humeroradial synostosis (HP:0003041) | 1.83275900 |
| 71 | Synostosis involving the elbow (HP:0003938) | 1.83275900 |
| 72 | Hip dysplasia (HP:0001385) | 1.82966444 |
| 73 | Retinal atrophy (HP:0001105) | 1.81354128 |
| 74 | Optic nerve hypoplasia (HP:0000609) | 1.80320996 |
| 75 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78063505 |
| 76 | Clumsiness (HP:0002312) | 1.77871169 |
| 77 | Heterochromia iridis (HP:0001100) | 1.77205726 |
| 78 | Absence seizures (HP:0002121) | 1.75975767 |
| 79 | Chorioretinal coloboma (HP:0000567) | 1.75832994 |
| 80 | Exotropia (HP:0000577) | 1.73211499 |
| 81 | Shoulder girdle muscle weakness (HP:0003547) | 1.71435284 |
| 82 | Abnormality of the intervertebral disk (HP:0005108) | 1.71127425 |
| 83 | Male infertility (HP:0003251) | 1.67940722 |
| 84 | Broad distal phalanx of finger (HP:0009836) | 1.67175736 |
| 85 | Large earlobe (HP:0009748) | 1.66975033 |
| 86 | Xanthomatosis (HP:0000991) | 1.66159174 |
| 87 | Occipital encephalocele (HP:0002085) | 1.65583697 |
| 88 | Hypoplasia of the fovea (HP:0007750) | 1.64619135 |
| 89 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.64619135 |
| 90 | Generalized myoclonic seizures (HP:0002123) | 1.64433187 |
| 91 | Spinal cord lesions (HP:0100561) | 1.61951671 |
| 92 | Syringomyelia (HP:0003396) | 1.61951671 |
| 93 | Anonychia (HP:0001798) | 1.60599194 |
| 94 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.59640854 |
| 95 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.59640854 |
| 96 | Abnormality of male internal genitalia (HP:0000022) | 1.58197907 |
| 97 | Scrotal hypoplasia (HP:0000046) | 1.56139533 |
| 98 | Congenital sensorineural hearing impairment (HP:0008527) | 1.52080388 |
| 99 | Thickened nuchal skin fold (HP:0000474) | 1.49730937 |
| 100 | Generalized tonic-clonic seizures (HP:0002069) | 1.49564553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP2K6 | 6.20470772 |
| 2 | TLK1 | 5.48800507 |
| 3 | MAP3K5 | 3.75787282 |
| 4 | MAP4K2 | 3.59797012 |
| 5 | SIK2 | 3.16255800 |
| 6 | TAOK2 | 12.3927802 |
| 7 | MAPKAPK3 | 1.86688159 |
| 8 | EEF2K | 1.76601472 |
| 9 | NME1 | 1.75947734 |
| 10 | INSRR | 1.62205851 |
| 11 | MAP3K8 | 1.56031430 |
| 12 | RIPK1 | 1.51284218 |
| 13 | FRK | 1.32733880 |
| 14 | CASK | 1.15699921 |
| 15 | PIK3CA | 0.94330235 |
| 16 | MAPKAPK5 | 0.94178680 |
| 17 | TRPM7 | 0.82397978 |
| 18 | OXSR1 | 0.78744769 |
| 19 | EPHB1 | 0.75110666 |
| 20 | MAPK13 | 0.72309547 |
| 21 | WNK4 | 0.71689004 |
| 22 | TRIM28 | 0.71297895 |
| 23 | EPHA3 | 0.68291805 |
| 24 | BCR | 0.68166432 |
| 25 | STK39 | 0.67748326 |
| 26 | CSNK1G3 | 0.65084817 |
| 27 | CSNK1A1L | 0.58761636 |
| 28 | FGFR2 | 0.58755686 |
| 29 | RIPK4 | 0.57918809 |
| 30 | MAP2K7 | 0.56439258 |
| 31 | CSNK1G2 | 0.55881416 |
| 32 | WNK3 | 0.55175034 |
| 33 | MAP3K4 | 0.53186022 |
| 34 | CSNK1G1 | 0.49068997 |
| 35 | RPS6KB2 | 0.48418800 |
| 36 | MELK | 0.48275047 |
| 37 | CCNB1 | 0.42402124 |
| 38 | SIK3 | 0.40121045 |
| 39 | HIPK2 | 0.39472785 |
| 40 | MARK1 | 0.36038147 |
| 41 | ADRBK2 | 0.29670270 |
| 42 | TTK | 0.28671222 |
| 43 | PINK1 | 0.28248792 |
| 44 | TNIK | 0.26653230 |
| 45 | PRKCG | 0.23099338 |
| 46 | MINK1 | 0.23084927 |
| 47 | NLK | 0.22883846 |
| 48 | MAPK7 | 0.18621748 |
| 49 | EPHA4 | 0.18135602 |
| 50 | PRKAA2 | 0.17508116 |
| 51 | PRKCZ | 0.17005461 |
| 52 | DYRK2 | 0.16987293 |
| 53 | PLK4 | 0.16454815 |
| 54 | TAF1 | 0.16418121 |
| 55 | MAPK11 | 0.14886041 |
| 56 | MARK3 | 0.14324049 |
| 57 | CSNK1A1 | 0.14137541 |
| 58 | CDK5 | 0.12980497 |
| 59 | MAP3K7 | 0.10624828 |
| 60 | AURKA | 0.09835338 |
| 61 | PAK3 | 0.09670420 |
| 62 | STK4 | 0.09650958 |
| 63 | BMPR1B | 0.09404830 |
| 64 | VRK2 | 0.08235181 |
| 65 | PRKAA1 | 0.08149282 |
| 66 | TAOK3 | 0.07389291 |
| 67 | ATR | 0.06946907 |
| 68 | PRKACB | 0.06834732 |
| 69 | STK11 | 0.06691983 |
| 70 | ADRBK1 | 0.06407999 |
| 71 | GRK1 | 0.06241379 |
| 72 | NUAK1 | 0.05377103 |
| 73 | RPS6KB1 | 0.05349972 |
| 74 | YES1 | 0.05003720 |
| 75 | PRKCQ | 0.04989035 |
| 76 | PDK1 | 0.04163092 |
| 77 | PHKG1 | 0.03161046 |
| 78 | PHKG2 | 0.03161046 |
| 79 | FGR | 0.02435359 |
| 80 | CHEK2 | 0.02183000 |
| 81 | CSNK1D | 0.01556171 |
| 82 | CDK8 | 0.01247189 |
| 83 | CSNK2A1 | 0.00360279 |
| 84 | OBSCN | 0.00297185 |
| 85 | MAPK9 | -0.0276949 |
| 86 | CDK1 | -0.0228819 |
| 87 | GRK5 | -0.0225355 |
| 88 | MUSK | -0.0221144 |
| 89 | PRKD1 | -0.0201063 |
| 90 | DDR2 | -0.0198095 |
| 91 | PTK2B | -0.0179201 |
| 92 | ATM | -0.0177409 |
| 93 | WEE1 | -0.0151162 |
| 94 | PDPK1 | -0.0108121 |
| 95 | MAPK8 | -0.0087578 |
| 96 | PLK2 | -0.0086727 |
| 97 | MST4 | -0.0085237 |
| 98 | MAPK15 | -0.0072224 |
| 99 | MARK2 | -0.0065946 |
| 100 | RET | -0.0008021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 5.46716361 |
| 2 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 3.73730530 |
| 3 | Cocaine addiction_Homo sapiens_hsa05030 | 3.27465163 |
| 4 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 3.14196047 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.85884992 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.72835109 |
| 7 | GnRH signaling pathway_Homo sapiens_hsa04912 | 2.70142408 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.52620982 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.10184676 |
| 10 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 2.05632399 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.98373304 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.84896729 |
| 13 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73479595 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.71149048 |
| 15 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.63849086 |
| 16 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.59665053 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57794573 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52425813 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52403769 |
| 20 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39565294 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.36950327 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32785685 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21788857 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21502991 |
| 25 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.18190133 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15913281 |
| 27 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15730201 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.08126473 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07934144 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06525669 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.06317509 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04831004 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04754492 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04458322 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03509112 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.01985869 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00569111 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00307487 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99675353 |
| 40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97072020 |
| 41 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94818055 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92862810 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92005501 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86740164 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84184173 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83869527 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82205689 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82076147 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80511549 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80225570 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78941674 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70378396 |
| 53 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68832757 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67082221 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66798234 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66343879 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 0.66120747 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65376177 |
| 59 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.64324984 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62146971 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.59586525 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59489229 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57975966 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55082503 |
| 65 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53740317 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51966400 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.49365753 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49089323 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47838473 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47094012 |
| 71 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47062371 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45812508 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45633815 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.45445634 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45012480 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44946186 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43472094 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41426748 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40640319 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37555178 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.37530483 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.37267137 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37038039 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36897835 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35726778 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35457882 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.35424090 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35233567 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35157935 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34035743 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.33510778 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.32375900 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.31400415 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.30822787 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.30634701 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30616715 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30474193 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.29485535 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28878715 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27876760 |

